CD8+ T cells that are specific for tumor-associated antigens can engage tumor cells in an antigen-specific manner, and these cells drive anti-tumor immunity by secreting effector cytokines, releasing cytotoxic molecules and inducing apoptosis in tumor cells (38). The gene discussed is CD8A; the disease is neoplasm.